Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLNX
51
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $158M | 0.24% |
1,333,878
+1,132,420
| +562% | +$114M |
|
52
Thermo Fisher Scientific
TMO
$233B
| $157M | 0.24% |
575,153
+31,502
| +6% | +$7.84M |
|
|
ARRS
53
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $157M | 0.24% |
4,974,398
+842,157
| +20% | +$26.4M |
|
54
Amgen
AMGN
$238B
| $155M | 0.23% |
815,311
-98,574
| -11% | -$18.8M |
|
55
Tenaris
TS
$26.6B
| $154M | 0.23% |
5,463,356
+2,346,866
| +75% | +$60.6M |
|
|
ETFC
56
DELISTED
E*Trade Financial Corporation
ETFC
| $154M | 0.23% |
3,307,740
-1,362,223
| -29% | -$64.9M |
|
57
Lowe's Companies
LOW
$121B
| $152M | 0.23% |
1,383,980
-1,425,713
| -51% | -$142M |
|
58
CMS Energy
CMS
$21.4B
| $151M | 0.23% |
2,723,633
+1,858,162
| +215% | +$98M |
|
59
Zoetis
ZTS
$32.1B
| $148M | 0.22% |
1,473,159
+1,458,780
| +10,145% | +$132M |
|
60
Estee Lauder
EL
$36.9B
| $148M | 0.22% |
892,075
+82,387
| +10% | +$12.1M |
|
61
SBA Communications
SBAC
$19.4B
| $146M | 0.22% |
729,742
-201,979
| -22% | -$36.6M |
|
62
Lamb Weston
LW
$7.38B
| $146M | 0.22% |
1,941,801
-959,058
| -33% | -$67.9M |
|
63
Lockheed Martin
LMT
$130B
| $143M | 0.21% |
475,605
+275,754
| +138% | +$80.9M |
|
64
Fidelity National Information Services
FIS
$21.3B
| $143M | 0.21% |
1,262,113
+416,731
| +49% | +$44.4M |
|
65
Ralph Lauren
RL
$22.2B
| $141M | 0.21% |
1,089,484
+982,261
| +916% | +$117M |
|
66
Diamondback Energy
FANG
$59B
| $141M | 0.21% |
1,384,523
+741,724
| +115% | +$76M |
|
67
Newmont
NEM
$139B
| $140M | 0.21% |
3,924,964
+3,153,680
| +409% | +$107M |
|
68
Evergy
EVRG
$18.7B
| $140M | 0.21% |
2,411,969
+19,038
| +0.8% | +$1.08M |
|
|
IDTI
69
DELISTED
Integrated Device Technology I
IDTI
| $139M | 0.21% |
2,847,424
+673,753
| +31% | +$32.6M |
|
|
SCHW
70
Charles Schwab
SCHW
$194B
| $139M | 0.21% |
3,241,664
+1,758,294
| +119% | +$79.4M |
|
|
GG
71
DELISTED
Goldcorp Inc
GG
| $138M | 0.21% |
12,080,553
+9,516,405
| +371% | +$102M |
|
72
Royal Caribbean
RCL
$78.1B
| $138M | 0.21% |
1,203,488
+127,376
| +12% | +$14.5M |
|
73
Broadcom
AVGO
$1.75T
| $137M | 0.21% |
4,565,750
-3,918,230
| -46% | -$106M |
|
|
PXD
74
DELISTED
Pioneer Natural Resource Co.
PXD
| $137M | 0.21% |
899,965
-531,484
| -37% | -$75M |
|
75
Citizens Financial Group
CFG
$29.4B
| $136M | 0.2% |
4,183,055
+888,318
| +27% | +$30.8M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.